Amanta Healthcare is a pharmaceutical formulation manufacturer incorporated in 1994. The company specialises in sterile liquid formulations and operates across multiple therapeutic segments, including fluid therapy, respiratory care, ophthalmic, diluents, and irrigation solutions. Its manufacturing facility, located in Hariyala, Kheda district, Gujarat, is spread across over 66,000 square meters and is equipped with multiple LVP and SVP lines using ABFS and ISBM technologies. The company is WHO-GMP compliant and holds ISO 9001:2015, ISO 13485:2016, ISO 14001:2015, and ISO 45001:2018 certifications.
IPO schedule
Issue open date
2025-09-01
Issue close date
2025-09-03
UPI mandate deadline
2025-09-03 (5 PM)
Allotment finalization
2025-09-04
Refund initiation
2025-09-08
Share credit
2025-09-08
Listing date
2025-09-09
Mandate end date
2025-09-18
Lock-in end date for anchor investors (50%)
2025-10-04
Lock-in end date for anchor investors (remaining)
2025-12-03
Financials
Financial Year Ended
March 2023
March 2024
March 2025
Total Assets
374.06
352.11
381.76
Revenue
262.69
281.60
276.09
Profit After Tax
-2.11
3.63
10.50
Issue size
Funds Raised in the IPO
Amount
Overall
₹126 crores
Fresh Issue
₹126 crores
Utilisation of proceeds
Purpose
INR crores (%)
Capital expenditure for setting up a new manufacturing line of SteriPort
70 (55.5%)
Capital expenditure for setting up a new manufacturing line for SVP
30.13 (24%)
General corporate purposes
25.87 (20.5%)
Strengths
Established in 1994 with a diversified pharmaceutical product portfolio
Advanced sterile liquid manufacturing across a wide volume range
Certified facility with ISO, WHO-GMP, and advanced technologies
Extensive domestic and global distribution and sales network
Experienced leadership with a skilled, qualified employee base
Risk factors
High customer concentration poses revenue stability and dependency risks
Delay in SteriPort/SVP expansion may impact growth plans
Promoter guarantees tied to loans may affect operations